These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 19682434

  • 1. Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers.
    Tharakan ST, Inamoto T, Sung B, Aggarwal BB, Kamat AM.
    Biochem Pharmacol; 2010 Jan 15; 79(2):218-28. PubMed ID: 19682434
    [Abstract] [Full Text] [Related]

  • 2. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB.
    Cancer Res; 2007 Apr 15; 67(8):3853-61. PubMed ID: 17440100
    [Abstract] [Full Text] [Related]

  • 3. Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors.
    Kamat AM, Tharakan ST, Sung B, Aggarwal BB.
    Cancer Res; 2009 Dec 01; 69(23):8958-66. PubMed ID: 19903839
    [Abstract] [Full Text] [Related]

  • 4. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.
    Kunnumakkara AB, Diagaradjane P, Anand P, Harikumar KB, Deorukhkar A, Gelovani J, Guha S, Krishnan S, Aggarwal BB.
    Int J Cancer; 2009 Nov 01; 125(9):2187-97. PubMed ID: 19623659
    [Abstract] [Full Text] [Related]

  • 5. Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway.
    Wang Y, Wu X, Zhou Y, Jiang H, Pan S, Sun B.
    Cancer Prev Res (Phila); 2016 Mar 01; 9(3):234-44. PubMed ID: 26667450
    [Abstract] [Full Text] [Related]

  • 6. Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells.
    Kamat AM, Sethi G, Aggarwal BB.
    Mol Cancer Ther; 2007 Mar 01; 6(3):1022-30. PubMed ID: 17363495
    [Abstract] [Full Text] [Related]

  • 7. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB, Diagaradjane P, Guha S, Deorukhkar A, Shentu S, Aggarwal BB, Krishnan S.
    Clin Cancer Res; 2008 Apr 01; 14(7):2128-36. PubMed ID: 18381954
    [Abstract] [Full Text] [Related]

  • 8. Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer.
    Harikumar KB, Kunnumakkara AB, Sethi G, Diagaradjane P, Anand P, Pandey MK, Gelovani J, Krishnan S, Guha S, Aggarwal BB.
    Int J Cancer; 2010 Jul 15; 127(2):257-68. PubMed ID: 19908231
    [Abstract] [Full Text] [Related]

  • 9. Induction of caspase mediated apoptosis and down-regulation of nuclear factor-κB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells.
    Jeon HG, Yoon CY, Yu JH, Park MJ, Lee JE, Jeong SJ, Hong SK, Byun SS, Lee SE.
    J Urol; 2011 Nov 15; 186(5):2084-93. PubMed ID: 21944112
    [Abstract] [Full Text] [Related]

  • 10. Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppression of the inflammatory microenvironment.
    Prasad S, Yadav VR, Sung B, Gupta SC, Tyagi AK, Aggarwal BB.
    Oncotarget; 2016 Mar 15; 7(11):13182-96. PubMed ID: 26909608
    [Abstract] [Full Text] [Related]

  • 11. {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.
    Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Yadav VR, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB.
    Cancer Res; 2010 Nov 01; 70(21):8695-705. PubMed ID: 20864511
    [Abstract] [Full Text] [Related]

  • 12. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
    Manu KA, Shanmugam MK, Ramachandran L, Li F, Fong CW, Kumar AP, Tan P, Sethi G.
    Clin Cancer Res; 2012 Apr 15; 18(8):2220-9. PubMed ID: 22351692
    [Abstract] [Full Text] [Related]

  • 13. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine.
    Prasad S, Yadav VR, Sung B, Reuter S, Kannappan R, Deorukhkar A, Diagaradjane P, Wei C, Baladandayuthapani V, Krishnan S, Guha S, Aggarwal BB.
    Clin Cancer Res; 2012 Sep 15; 18(18):4942-53. PubMed ID: 22832932
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy of VEGF-trap and gemcitabine results in improved anti-tumor efficacy in a mouse lung cancer model.
    Zhou S, Yang Y, Yang Y, Tao H, Li D, Zhang J, Jiang G, Fang J.
    PLoS One; 2013 Sep 15; 8(7):e68589. PubMed ID: 23874680
    [Abstract] [Full Text] [Related]

  • 15. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer.
    Bisht S, Mizuma M, Feldmann G, Ottenhof NA, Hong SM, Pramanik D, Chenna V, Karikari C, Sharma R, Goggins MG, Rudek MA, Ravi R, Maitra A, Maitra A.
    Mol Cancer Ther; 2010 Aug 15; 9(8):2255-64. PubMed ID: 20647339
    [Abstract] [Full Text] [Related]

  • 16. Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.
    Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB.
    Int J Cancer; 2012 Aug 01; 131(3):E292-303. PubMed ID: 21935918
    [Abstract] [Full Text] [Related]

  • 17. Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: Involvement of NF-κB signaling pathway.
    Wang Y, Zhou Y, Jia G, Han B, Liu J, Teng Y, Lv J, Song Z, Li Y, Ji L, Pan S, Jiang H, Sun B.
    Biochem Pharmacol; 2014 Apr 01; 88(3):322-33. PubMed ID: 24522113
    [Abstract] [Full Text] [Related]

  • 18. [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine].
    Liu A, Hu YS, Wang ZH, Tang LL, Ke PY, Lin SZ.
    Yao Xue Xue Bao; 2011 Feb 01; 46(2):146-52. PubMed ID: 21542284
    [Abstract] [Full Text] [Related]

  • 19. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
    Muramaki M, Miyake H, Hara I, Kawabata G, Kamidono S.
    J Urol; 2004 Oct 01; 172(4 Pt 1):1485-9. PubMed ID: 15371876
    [Abstract] [Full Text] [Related]

  • 20. Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.
    Waters JA, Matos J, Yip-Schneider M, Aguilar-Saavedra JR, Crean CD, Beane JD, Dumas RP, Suvannasankha A, Schmidt CM.
    Surgery; 2015 Oct 01; 158(4):881-8; discussion 888-9. PubMed ID: 26209568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.